Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436.SS)
CNY 220.76
(0.79%)
CNY 220.76
(0.79%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 10.05 Billion CNY | 14.77% |
| 2022 | 8.69 Billion CNY | 8.38% |
| 2021 | 8.02 Billion CNY | 23.2% |
| 2020 | 6.51 Billion CNY | 13.78% |
| 2019 | 5.72 Billion CNY | 20.06% |
| 2018 | 4.76 Billion CNY | 28.33% |
| 2017 | 3.71 Billion CNY | 60.85% |
| 2016 | 2.3 Billion CNY | 22.45% |
| 2015 | 1.88 Billion CNY | 29.7% |
| 2014 | 1.45 Billion CNY | 4.16% |
| 2013 | 1.39 Billion CNY | 19.19% |
| 2012 | 1.17 Billion CNY | 14.64% |
| 2011 | 1.02 Billion CNY | 17.78% |
| 2010 | 867.31 Million CNY | 24.84% |
| 2009 | 694.74 Million CNY | 6.93% |
| 2008 | 649.74 Million CNY | 9.56% |
| 2007 | 593.06 Million CNY | 13.57% |
| 2006 | 522.2 Million CNY | 24.68% |
| 2005 | 418.82 Million CNY | 65.22% |
| 2004 | 253.48 Million CNY | 18.68% |
| 2003 | 213.59 Million CNY | 0.74% |
| 2002 | 212.03 Million CNY | 9.36% |
| 2001 | 193.89 Million CNY | 5.42% |
| 2000 | 183.92 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 2.79 Billion CNY | 12.91% |
| 2024 Q2 | 2.47 Billion CNY | -21.21% |
| 2024 Q1 | 3.14 Billion CNY | 28.6% |
| 2023 Q2 | 2.41 Billion CNY | -8.13% |
| 2023 Q3 | 2.55 Billion CNY | 5.75% |
| 2023 FY | 9.97 Billion CNY | 14.77% |
| 2023 Q1 | 2.62 Billion CNY | 26.53% |
| 2023 Q4 | 2.44 Billion CNY | -4.2% |
| 2022 FY | 8.69 Billion CNY | 8.38% |
| 2022 Q4 | 2.07 Billion CNY | -5.24% |
| 2022 Q1 | 2.34 Billion CNY | 22.95% |
| 2022 Q2 | 2.07 Billion CNY | -11.65% |
| 2022 Q3 | 2.19 Billion CNY | 5.72% |
| 2021 FY | 8.02 Billion CNY | 23.2% |
| 2021 Q1 | 2 Billion CNY | 38.93% |
| 2021 Q4 | 1.9 Billion CNY | -15.6% |
| 2021 Q3 | 2.26 Billion CNY | 22.53% |
| 2021 Q2 | 1.84 Billion CNY | -7.74% |
| 2020 Q2 | 1.53 Billion CNY | -10.65% |
| 2020 Q3 | 1.82 Billion CNY | 19.05% |
| 2020 Q4 | 1.44 Billion CNY | -20.99% |
| 2020 FY | 6.51 Billion CNY | 13.78% |
| 2020 Q1 | 1.71 Billion CNY | 24.17% |
| 2019 Q4 | 1.38 Billion CNY | -4.6% |
| 2019 Q3 | 1.44 Billion CNY | 2.64% |
| 2019 FY | 5.72 Billion CNY | 20.06% |
| 2019 Q1 | 1.48 Billion CNY | 25.76% |
| 2019 Q2 | 1.41 Billion CNY | -5.0% |
| 2018 FY | 4.76 Billion CNY | 28.33% |
| 2018 Q1 | 1.22 Billion CNY | 26.1% |
| 2018 Q3 | 1.18 Billion CNY | 0.03% |
| 2018 Q4 | 1.18 Billion CNY | -0.15% |
| 2018 Q2 | 1.18 Billion CNY | -3.31% |
| 2017 Q1 | 860.32 Million CNY | 25.91% |
| 2017 Q4 | 969.25 Million CNY | -2.28% |
| 2017 Q2 | 892.51 Million CNY | 3.74% |
| 2017 FY | 3.71 Billion CNY | 60.85% |
| 2017 Q3 | 991.86 Million CNY | 11.13% |
| 2016 Q1 | 468.77 Million CNY | -15.36% |
| 2016 Q4 | 683.27 Million CNY | 2.71% |
| 2016 Q3 | 665.24 Million CNY | 35.31% |
| 2016 Q2 | 491.65 Million CNY | 4.88% |
| 2016 FY | 2.3 Billion CNY | 22.45% |
| 2015 Q2 | 434.54 Million CNY | 14.56% |
| 2015 FY | 1.88 Billion CNY | 29.7% |
| 2015 Q4 | 553.83 Million CNY | 6.92% |
| 2015 Q3 | 517.99 Million CNY | 19.2% |
| 2015 Q1 | 379.3 Million CNY | 3.6% |
| 2014 Q4 | 366.13 Million CNY | 13.44% |
| 2014 FY | 1.45 Billion CNY | 4.16% |
| 2014 Q1 | 377.78 Million CNY | 17.68% |
| 2014 Q3 | 322.76 Million CNY | -16.63% |
| 2014 Q2 | 387.17 Million CNY | 2.48% |
| 2013 Q1 | 338 Million CNY | 23.88% |
| 2013 Q2 | 376.94 Million CNY | 11.52% |
| 2013 Q3 | 359.9 Million CNY | -4.52% |
| 2013 Q4 | 321.02 Million CNY | -10.8% |
| 2013 FY | 1.39 Billion CNY | 19.19% |
| 2012 Q4 | 272.85 Million CNY | -16.1% |
| 2012 Q3 | 325.2 Million CNY | 5.22% |
| 2012 Q2 | 309.08 Million CNY | 17.07% |
| 2012 Q1 | 264.01 Million CNY | -3.34% |
| 2012 FY | 1.17 Billion CNY | 14.64% |
| 2011 Q4 | 273.12 Million CNY | 4.59% |
| 2011 FY | 1.02 Billion CNY | 17.78% |
| 2011 Q3 | 261.13 Million CNY | 16.49% |
| 2011 Q2 | 224.17 Million CNY | -14.8% |
| 2011 Q1 | 263.12 Million CNY | 19.8% |
| 2010 FY | 867.31 Million CNY | 24.84% |
| 2010 Q3 | 233.88 Million CNY | 5.61% |
| 2010 Q2 | 221.46 Million CNY | 15.15% |
| 2010 Q4 | 219.64 Million CNY | -6.09% |
| 2010 Q1 | 192.32 Million CNY | 21.74% |
| 2009 Q4 | 157.98 Million CNY | -19.6% |
| 2009 Q2 | 188.63 Million CNY | 24.4% |
| 2009 Q1 | 151.63 Million CNY | 2.83% |
| 2009 Q3 | 196.49 Million CNY | 4.17% |
| 2009 FY | 694.74 Million CNY | 6.93% |
| 2008 Q3 | 164.24 Million CNY | -1.57% |
| 2008 Q4 | 147.45 Million CNY | -10.22% |
| 2008 FY | 649.74 Million CNY | 9.56% |
| 2008 Q1 | 171.17 Million CNY | 35.3% |
| 2008 Q2 | 166.86 Million CNY | -2.51% |
| 2007 Q4 | 126.51 Million CNY | -19.85% |
| 2007 Q3 | 157.84 Million CNY | -2.6% |
| 2007 Q2 | 162.05 Million CNY | 10.49% |
| 2007 Q1 | 146.66 Million CNY | 17.14% |
| 2007 FY | 593.06 Million CNY | 13.57% |
| 2006 Q3 | 132.53 Million CNY | -10.19% |
| 2006 Q4 | 125.2 Million CNY | -5.53% |
| 2006 Q2 | 147.57 Million CNY | 26.25% |
| 2006 FY | 522.2 Million CNY | 24.68% |
| 2006 Q1 | 116.89 Million CNY | -4.27% |
| 2005 FY | 418.82 Million CNY | 65.22% |
| 2005 Q4 | 122.1 Million CNY | -9.01% |
| 2005 Q3 | 134.19 Million CNY | 16.79% |
| 2005 Q2 | 114.9 Million CNY | 141.33% |
| 2005 Q1 | 47.61 Million CNY | -35.97% |
| 2004 Q4 | 74.36 Million CNY | 19.54% |
| 2004 Q2 | 87.14 Million CNY | 192.77% |
| 2004 FY | 253.48 Million CNY | 18.68% |
| 2004 Q1 | 29.76 Million CNY | -56.47% |
| 2004 Q3 | 62.21 Million CNY | -28.61% |
| 2003 Q3 | 45 Million CNY | -15.15% |
| 2003 Q2 | 53.03 Million CNY | 12.42% |
| 2003 Q4 | 68.37 Million CNY | 51.95% |
| 2003 FY | 213.59 Million CNY | 0.74% |
| 2003 Q1 | 47.17 Million CNY | -29.39% |
| 2002 FY | 212.03 Million CNY | 9.36% |
| 2002 Q4 | 66.81 Million CNY | 31.63% |
| 2002 Q3 | 50.75 Million CNY | 0.0% |
| 2001 FY | 193.89 Million CNY | 5.42% |
| 2000 FY | 183.92 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 22.81 Billion CNY | 55.922% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 6.73 Billion CNY | -49.396% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 2.31 Billion CNY | -335.08% |
| Aurora Optoelectronics Co.,Ltd. | 327.9 Million CNY | -2967.471% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 121.77 Million CNY | -8159.664% |
| NanJing Pharmaceutical Company Limited | 53.58 Billion CNY | 81.231% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 1.28 Billion CNY | -683.362% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 3.07 Billion CNY | -227.061% |